I believe the trial they're discussing that ends in April

New Post Public Reply Private Reply Replies (1) Message Board
GaryM FELLER #6022
356
I believe the trial they're discussing that ends in April is the safety trial, the only one that is found in the FDA Clinical Trials database.

As for efficacy, it's been done with preclinical protocol's that apparently use human forms of psoriasis, but it's not tested on people. It's effective and probably mirrors what will happen with people, but it's my understanding that after safety's proven the Psoriasis Cream can be sold in Green Cross stores here in the U.S., and apparently in other countries.

I wish I could say that I'm certain the company is right about this, they probably are, but until I can see it in the Green Cross stores, I can't be certain.

That said, anyone who spends any time on the net is virtually bombarded with products intended to improve our health. Almost every one of these say they've run trials, but virtually none are FDA approved as drugs. While I don't believe our product can be marketed this way, because it contains cannabis, the point is, these products either find the shelves in stores, or they're marketed on the net, or both.

If this Psoriasis Cream didn't have cannabis in it, you could probably put it on the market today, without any form of safety trial. Once the safety trial determines it to truly be safe, subject to laws on medical marijuana, I believe we should be good to go.

To me the real question is, will it work on acne, sunburn, cuts, muscle aches, etc. We really have no idea what the cream is capable of, but I believe that if you put it into the marketplace, and have a forum where people can post results, we'll find that it may have benefits in all sorts of ways. Of course the proof will be anecdotal, but as usage builds and anecdotes increase, no telling how many things will benefit from the cream.

Of course some of the benefits could be imaginary. If I tried the cream on a cut and thought it healed faster it would be a matter of my perception. The FDA would only say it was true if hundreds of people were cut, and cream was applied to each, but some of the cream had no cannabis, then the results were studied to determine if the cannabis cream improved healing. No doubt the same would have to be done with sunburn, or anything else you might name as what's observed might still be observed if a placebo product were used, as long as you thought the placebo was giving you a benefit.

I do believe that placebo's can have an effect on outcome, but I believe that when the FDA has a huge battery of evidence on what the SOC does, all in a clinical trial should be given the trial product, and comparison be drawn against the statistical data for the SOC. Psoriasis treatments are pretty well established, I believe that all who try the cream will know that it's working as well, or better than treatment they've previously tried, at least when comparing with other topical products. In all fairness, if you compare it with products that are taken internally, and they're known to have serious side effects, the use of the topical might still be preferable, even if it wasn't quite as effective.

Gary
1

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Bakery China's International Buyer Surge: A 50% Boost

Updated Category News Views 6

Look Who's Lining Up for Chinese Pastries Alright, here we go. China's baking scene is pulling in audiences far and wide, as if the whole world suddenly caught a whiff of their freshest, steaming buns. The 11th Bakery China Autumn, recently wrapped up at the Wuhan International Expo Center, saw a 50% rise in international buyers. This stat gives you that warm and cozy...

Continue Reading
Hospitals Face $392M Squeeze Under Medicare's CJR-X

Updated Category News Views 40

Medicare's CJR-X Challenges Hospitals 2028 is setting up to be a year hospitals across the U.S. remember, not with a smile, but likely with clenched teeth. Medicare's CJR-X model is ready to put about 2,217 hospitals in a financial vise over hip, knee, and ankle replacements. Going into effect on January 1, 2028, this mandate turns health networks' profit dreams into a...

Continue Reading
WareSpace Expands in U.S. with Key Site Acquisitions

Updated Category News Views 28

WareSpace's National Growth Strategy: A New Expansion Chapter They say everything's bigger in Texas, but WareSpace is showing that smaller can be mighty impactful too. With its shrewd acquisition of sites in Houston's Inner Loop and Fremont's Warm Springs corridor, WareSpace is playing it smart, appeasing that roaring demand for tiny but mighty warehouse spaces across...

Continue Reading
Greenberg Traurig's Stars Shine in Delaware's Legal Scene

Updated Category News Views 27

Five Lawyers, One Prestigious List Eating lunch today, I nearly dropped my sandwich when I read that five top-notch attorneys from Greenberg Traurig have snagged spots on Delaware Today's 2026 Top Lawyers List. This isn't your everyday pat on the back; it's Delaware, the heavyweight champ of corporate law, after all. The Legal Eagles of Greenberg Traurig Kicking off this...

Continue Reading
FGII and tZERO Merger Under Scrutiny: Is it Fair?

Updated Category News Views 8

Sitting at the Crossroads of M&A Scrutiny Alright, it's time to put on our skeptical hats. Out in the world of mergers and acquisitions, not every deal glimmers with gold. You've got FG Imperii Acquisition Corp. (NASDAQ: FGII) under the lens, with a merger alongside tZERO Group, Inc. stirring up a storm. The folks over at Monteverde & Associates, an M&A Class Action Firm...

Continue Reading
Xi Jinping's Vision for China's Financial Evolution

Updated Category News Views 145

Xi's Blueprint for Financial Strength Xi Jinping isn't just whistling Dixie when it comes to reshaping China's financial landscape. His vision is about more than pushing paper; it's about embedding honesty, prudence, and traditional values into the very DNA of China's financial sector. When he talks about enhancing both hard and soft power, he’s thinking wider than...

Continue Reading
Coretek Joins CRN's Elite AI Innovators of 2026

Updated Category News Views 26

Coretek's Leap to AI Innovator Status Here we are, folks. Another announcement hits the wires that showcases a company's ascent amid the swelling AI tide. Coretek, hailing from Farmington Hills, managed to snag a spot on CRN's inaugural 2026 AI Innovators list. No small potatoes, if you ask me, considering the competition on this playing field. Why the fuss? It's about...

Continue Reading
MSA Safety's Q3 2026: Strong Sales, Strategic Moves

Updated Category News Views 65

MSA's Stellar Growth Amidst Strategic Shifts Ah, the rush of quarterly results, and today we're eyeballing MSA Safety's third quarter of 2026. If numbers light your fire, MSA's boasting some scorching ones right now. The company's net sales shot up to $536 million—a 15% leap from the previous year. Now, in this dog's game of margins and market maneuvers, that's a solid...

Continue Reading
Yuhang's Innovative Tech: Journalists Get A Front Row Seat

Updated Category News Views 223

A Sneak Peek into Yuhang's Technological Leap Imagine strolling through a place where technology and nature coexist in harmony. That's exactly what journalists from around the globe got to experience during their recent jaunt to Yuhang District in Hangzhou. We're talking about reps from South Korea, Turkey, the U.S., and even Cuba getting a firsthand look at Yuhang's...

Continue Reading
GNSS Simulator Market: $425M by 2031, Key Insight

Updated Category News Views 17

GNSS Simulator Market: Gadgets Meet Growth A market that's been quietly bubbling away on the back burner is about to boil over: The GNSS Simulator Market, pegged at a neat $424.6 million by 2031. Yeah, it might be niche, but those in the know can't get enough of these satellite-signal replicators. Why GNSS Simulators are Crushing It There's a bunch of reasons why GNSS...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating the LBJ Express: A Decade of Transformational Growth

Updated Category News Views 247

LBJ Express: A Milestone in Infrastructure and Mobility The LBJ Express marks a significant milestone, celebrating its tenth anniversary as a transformative project that has improved mobility and fostered economic growth in the region. Originally opened in September 2015, this impressive 13-mile corridor runs from Interstate 35E through to U.S. 75 along the busy...

Continue Reading
Exploring Growth in the Global Cosmetic Manufacturing Sector

Updated Category News Views 276

Understanding the Rising Cosmetic Manufacturing Market As we dive into the world of beauty and aesthetics, one cannot overlook the vast potential within the cosmetic manufacturing industry. A recent report highlights that the global revenue from the cosmetic manufacturing sector is set to experience significant growth, with projections estimating a remarkable valuation of...

Continue Reading
Navigating Market Trends: Liquidity and Buybacks Drive Growth

Updated Category News Views 190

Market Resilience Amid Liquidity and Buyback Activities The current state of the market presents an intriguing picture, balancing risks while feeling surprisingly secure. It's akin to gliding on a fortified layer of fiscal stability, supported by strong monetary influences and persistent retail investments. Recent fluctuations seem to serve merely as a trial of market...

Continue Reading
AirSculpt Technologies Shares Second Quarter Insights

Updated Category News Views 135

AirSculpt Technologies Reports First Quarter Fiscal 2025 Results AirSculpt Technologies, Inc. (NASDAQ:AIRS), recognized as a national leader in premium body contouring procedures, has shared its financial performance for the first quarter. Despite some challenges, the company is poised for future growth as it continues to innovate in the field of body aesthetics....

Continue Reading
Winshear Gold's Significant Move: Earn-In Agreement on TBGP

Updated Category News Views 147

Winshear Gold Corp's Strategic Earn-In Agreement Winshear Gold Corp. (TSXV: WINS) is making waves in the mineral exploration industry with its newly announced agreement concerning the notable Thunder Bay Gold Project (TBGP). The company, headquartered in Vancouver, is set to earn a 100% interest in the expansive 360 square kilometers of the Thunder Bay region, a site that...

Continue Reading